Cancer Management Guidelines

Chronic Lymphocytic Leukemia (CLL)
Publications

Updated: Februaryr 2011

  1. Dreger P, Döhner H, Ritgen M, Böttcher, Busch R, Dietrich S, Bunjes D, Cohen S, Schubert J, Hegenbart U, Beelen D, Zeis M, Stadler M, Hasenkamp J, Uharek L, Scheid C, Humpe A, Zenz T, Winkler D, Hallek M, Kneba M, Schmitz N, Stilgenbauer S. Allogeneic stem cell transplantation provides durable disease control in poorrisk chronic lymphocytic leukemia: long-term clinical and MRD results of the GCLLSG CLL3X trial. Blood 116(14):2438-2447, 2010.
     Dreger P 2010 Blood
  2. Gerrie AS, Gillan TL, Bruyere H, Chan MJ, Dalal C, Toze CL. Impact of Immunoglobulin Heavy Chain (IGH) Translocations in Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality. Blood (ASH Annual Meeting Abstracts), November 2010; 116:2434.
     Gerrie A 2010 ASH Abstract
  3. Toze C, Dalal CB, Gillan TL, Nevill TJ, Barnett MJ, Nantel SH, Hogge DE, Forrest DL, Sutherland H, Song K, Broady R, Power M, Narayanan S, Smith CA, Shepherd J. Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes. Blood (ASH Annual Meeting Abstracts), November 2010; 116:3465.
     Toze C 2010 ASH Abstract
  4. Dreger P. Allotransplantation for chronic lymphocytic leukemia. American Society of Hematology 2009, 602-609.
     Dreger P 2009 ASH
  5. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the InternationalWorkshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:5446-5456, 2008.
     Hallek M 2008 Blood

  6. Schetelig J, van Biezen A, Brand R, Caballero D, Martino R, Itala M, Garcia-Marco JA, Volin L, Schmitz N, Schwerdtfeger R, Ganser A, Onida F, Mohr B, Stilgenbauer S, Bornhäuser M, de Witte T, Dreger P. Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis. J Clin Oncol 26:5094-5100, 2008.
     Schetelig J 2008 J Clin Oncol

 

The information contained in these guidelines is a statement of consensus of Leukemia/BMT Program of BC professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. Use of these guidelines and documents is at your own risk and is subject to the Leukemia/BMT Program of BC’s terms of use available at Terms of Use.

Privacy Statement
|
Terms of Use
|
hemwebcontact@bccancer.bc.ca
| visitor ip address: 38.107.179.244
© 2011 Leukemia/BMT Program of BC